Document: Relestat eye drops, solution ENG PL change

• Relestat eye drops, solution PL
• Relestat eye drops, solution ENG PL

---

Package leaflet: Information for the user

Relestat, 0.5 mg/ml, eye drops, solution

Epinastine hydrochloride

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

• Keep this leaflet. You may need to read it again.

• If you have any further questions, ask your doctor or pharmacist.

• This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.

• If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

What is in this leaflet

Relestat is an anti-allergic medicine.

It is an eye drops solution used to treat the symptoms of seasonal allergic conjunctivitis, a seasonal allergic disease affecting the eye. The main symptoms treated by Relestat include watery eyes and eyes or eyelids which are itchy, red or swollen.

Do not use Relestat:

Warnings and precautions

Talk to your doctor or pharmacist before using Relestat.

• if you wear soft contact lenses: you must remove them before using the Relestat eye drops. After using Relestat, wait at least 15 minutes before putting your lenses back in. See also in Section 2, “Relestat contains benzalkonium chloride”.

• if you have to use any other eye drops during treatment with Relestat: leave at least 10 minutes between putting in Relestat and the other drops.

Other medicines and Relestat

Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.

If you have to use any other eye drops during treatment with Relestat, please see above under “Warnings and precautions” in this section.

Pregnancy and breast-feeding

Pregnancy

If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.

Breast-feeding

It is not known whether Relestat passes into breast milk. Ask your doctor or pharmacist for advice before using this medicine during breast-feeding.

Driving and using machines

Your sight may become blurred for a short time just after using Relestat. You should not drive or use machines until your sight is clear again.

Relestat contains benzalkonium chloride

Relestat contains a preservative, called benzalkonium chloride, that can discolour soft contact lenses and may cause eye irritation.

If you wear soft contact lenses (also called hydrophilic lenses) you must remove them before using the Relestat eye drops. After using Relestat, you have to wait at least 15 minutes before putting your lenses back in.

Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.

Use in children

Relestat should not be used in children below 12 years of age.

Use in adults and adolescents (12 years of age and older)

The recommended dose is 1 drop in each eye that needs treatment, twice a day, for example in the morning and in the evening.

You should use Relestat every day that you experience eye symptoms during the allergy season but for no longer than 8 weeks.

Instructions for use

You must not use the bottle if the tamper-proof seal on the bottle neck is broken before you first begin to use it. Apply your eye drops in the following way:

If a drop misses your eye, try again.

To avoid contamination of the solution in the bottle, do not let the tip of the dropper touch your eye or anything else.

Replace and tighten the cap straight after use.

Wipe off any excess liquid from your cheek with a clean tissue.

The proper application of your eye drops is very important. If you have any questions ask your doctor or pharmacist.

If you use more Relestat than you should

If you use more drops of Relestat than you should, it is unlikely to cause you any harm. Put your next drop(s) in at the usual time. If you are worried, talk to your doctor or pharmacist.

If you forget to use Relestat

If you forget a dose apply it as soon as you remember, unless it is almost time for your next dose, in which case you should miss out the forgotten dose. Then, use your next dose at the usual time and continue with your normal routine.

Do not use a double dose to make up for a forgotten dose.

If you stop using Relestat

Relestat should be used as advised by your doctor. If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

Like all medicines, this medicine can cause side effects, although not everybody gets them. None of the side effects are likely to be serious; most side effects are likely to be mild and only affect the eye.

If the following happens, stop using Relestat and contact your doctor immediately or go to your nearest hospital:

The following side effects may also occur:

Common (may affect up to 1 in 10 people)

Uncommon (may affect up to 1 in 100 people)

General side effects:

• headache

• swelling and irritation inside the nose, which may cause a runny or blocked nose and sneezing

• unusual taste in your mouth

Side effects affecting the eye:

• red eyes

• dry eyes

• itchy eyes

• difficulty in seeing clearly

• discharge from the eyes

Patients have also reported the following side effects:

• increased tear production

• eye pain

Other side effects reported with eye drops containing phosphate

In very rare cases, some patients with severe damage to the clear layer at the front of the eye (the cornea) have developed cloudy patches on the cornea due to calcium build-up during treatment.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist.This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine

[To be completed nationally]

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the label of the bottle and on the box after EXP.

Do not use this medicine if you notice that the eye drops have shown signs of deterioration, for example change in colour, and take the product back to your pharmacist.

Do not store above 25°C.

Keep the bottle in the box in order to protect from light.

You must throw away the bottle 28 days after you first opened it, even if there are still some drops left. This will guard against infection. To help you remember, write down the date that you opened it in the space on the box.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

What Relestat contains

• The active substance is epinastine hydrochloride. One ml of eye drops, solution, contains 0.5 mg of epinastine hydrochloride.

• The other ingredients are benzalkonium chloride (a preservative), disodium edetate, sodium chloride, sodium dihydrogen phosphate dihydrate, sodium hydroxide/hydrochloric acid (to adjust pH) and purified water.

What Relestat looks like and contents of the pack

Relestat is a clear and colourless eye drops solution in a plastic bottle with a screw-cap. When unopened, each bottle is about half full and contains 5 ml of solution.

Each pack contains 1 bottle.

Marketing Authorisation Holder and Manufacturer

[To be completed nationally]

This medicinal product is authorised in the Member States of the EEA under the following names:

Name of the Member State	Name of the medicinal product
Austria, Germany	RELESTAT 0,5 mg/ml Augentropfen
Belgium	RELESTAT, 0,5 mg/ml, oogdruppels, oplossing
Czech Republic	PURIVIST 0.5 mg/ml oèní kapky, roztok
Denmark, Greece, Luxemburg, Poland, Sweden	RELESTAT
France	PURIVIST (0.5 mg/ml, collyre en solution)
Hungary	RELESTAT 0,5 mg/ml oldatos szemcsepp
Ireland, United Kingdom	RELESTAT, 0.5 mg/ml, eye drops solution
Italy	RELESTAT, 0,5 mg/ml, collirio, soluzione
Netherlands	RELESTAT, oogdruppels, oplossing, 0,5 mg/ml
Portugal	RELESTAT, 0.5 mg/ml, colírio, solução
Slovak Republic	PURIVIST
Spain	RELESTAT 0.5 mg/ml colirio en solución

This leaflet was last revised in 25 March 2015